Physician profile
David J Chao
NPI 1730290289
$2,769.04
in general payments reported to CMS, 2019-2025
23 companies · $68.61 in 2025
The $68.61 reported for 2025 was less than what a typical Sports Medicine (Orthopaedic Surgery) provider received nationally (typical 2025 total: $686).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,705 · 2020: $257 · 2021: $434 · 2022: $201 · 2023: $68.84 · 2024: $34.46 · 2025: $68.61.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $172.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $171.91 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sientra, INC. | $900.00 | 2019 | |
| Zimmer Biomet Holdings, INC. | $769.61 | 2019-2024 | Quattro |
| Trice Medical, INC. | $188.76 | 2019 | |
| Stryker Corporation | $165.55 | 2019-2022 | |
| Smith+Nephew, INC. | $110.31 | 2021-2025 | Evos Mini |
| Pacira Therapeutics, INC. | $91.64 | 2020-2021 | |
| Integra Lifesciences Corporation | $82.11 | 2019-2022 | |
| Tela Bio, INC. | $55.55 | 2021-2022 | |
| Acera Surgical, INC. | $54.81 | 2023-2024 | Restrata Wound Matrix |
| Bioventus LLC | $51.16 | 2022-2025 | Xcell |
| Depuy Synthes Sales INC. | $40.89 | 2021-2025 | Milagro |
| Axogen | $39.16 | 2021-2023 | Avance Nerve Graft |
| Acell, INC. | $36.46 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $30.42 | 2022 | |
| Lilly USA, LLC | $23.04 | 2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $21.32 | 2022 | |
| Misonix INC | $18.96 | 2019 | |
| Ferring Pharmaceuticals INC. | $18.77 | 2019 | |
| Fidia Pharma USA INC. | $17.52 | 2019 | |
| Ermi LLC | $17.18 | 2021 | |
| Next Science LLC | $16.59 | 2020 | |
| Medartis INC. | $12.57 | 2021 | |
| Apyx Medical Corporation | $6.66 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Chao listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.